Just to clarify (or beat a dead horse), NP did NOT
Post# of 145904
![](/assets/46931549/no_avatar_available_thumb.jpg)
The former would be dilution and terrible. The latter is ordinary, expected and probably required business. The company needs the A/S count headroom. The role of mgmt and the BOD is then to work to use as little of that authorized headroom as possible -- or not at all if the stars align.
I'd be willing to bet they increase the A/S count by 100-150M (requires shareholder approval). But that they will continue to issue shares at a small drip like they have for the past 9+ years that I have been in the stock. The only caveat would be if they do a secondary offering coincident with an uplist. Which I would be fine with as well, presuming it is done with the right institutional investors.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)